Rating: Cautiously Bullish ｜ Target Price: HKD 5.0–6.2 (base-case fair value, 12–18 months) ｜ Current Price: HKD 3.965 (close as of 2026-09-01) ｜ Margin of Safety: ~26% (vs. base-case fair value floor of HKD 5.0) ｜ Market Cap: HKD 2.193 billion (based on 553.03 million ex-treasury shares)
Key Note: This stock's average daily turnover is only about 0.12%–0.32% of market cap (samples across different bases: HKD 2.73 million–7.00 million/day), close to the low-liquidity warning threshold. It was removed from Stock Connect in March 2025, making large capital inflows/outflows costly; position sizing should follow low-liquidity stock discipline.
AInnovation is a leading niche player in China's "AI + Manufacturing" sub-sector: No.1 market share in industrial large-model applications per IDC (cited in the FY2025 annual report), No.5 in large-model platform privatization (latest basis in the 2026 interim report, the only manufacturing-focused vendor among the top five), consecutive revenue recovery (FY2025 +23.8%, H1 2026 +18.6%), gross margin steadily rising to 35.4%, and in H1 2026 it posted its first-ever half-year adjusted profit since listing (RMB 3.19 million). At HKD 3.965, the stock trades at ~0.70x EV/Sales 2026E, with net cash of ~HKD 735 million representing 33.5% of market cap. The market is essentially pricing it as "a project-based systems integrator with ~3% steady-state net margin," paying almost nothing for the industry-inflection option driven by "policy + penetration" — cheapness is the core of this thesis; quality improvement, not yet fully proven, is the core constraint.
Three constraints must be squarely faced. First, the adjusted-profit turnaround is a borderline outcome of "add-backs slightly exceeding the loss" — adding back RMB 48.3 million of SBC (77% of the period loss), the adjusted figure excluding government grants of RMB 9.22 million is actually about -RMB 6.04 million, and the statutory net loss attributable to shareholders widened 15.9% YoY. Second, leading indicators are weakening — contract liabilities fell 61.3% from the start of the year, and financial-asset impairment of RMB 35.6 million in six months already exceeded the FY2025 full year; the company has explained neither. Third, the discount unwind lacks institutional sponsorship — after Stock Connect removal there is no southbound flow, daily turnover is below 0.2% of market cap, and of the HKD 100 million buyback mandate only ~9.6% has been executed, with treasury shares unchanged in monthly filings since July 2026. Cheap can stay cheap for a long time; realization depends on two hard catalysts: the March 2027 annual report (confirmation of full-year adjusted profitability) and policy-driven orders in 2026Q4–2027H1. Three scenarios: Bear HKD 1.5–2.0 (30% probability), Base HKD 5.0–6.2 (50%), Bull HKD 9.2–10.3 (20%), probability-weighted fair value ~HKD 5.3 (~+33% vs. current price).
Market environment: Small-cap HK AI stocks are in a structurally discounted funding environment. The company was removed from Stock Connect on 2025-03-10 (linked to the Hang Seng Composite Index periodic review); current market cap is ~HKD 2.19 billion vs. the estimated Stock Connect inclusion threshold of ~HKD 9.307 billion — no medium-term path back; no sell-side earnings updates in 2026 (visible coverage is stale 2025 values); attention itself is decaying. This environment means the discount unwind can only be driven by "hard earnings data + company buybacks," not funding-style rotation.
Key changes underway: ① Borderline crossing of the profitability threshold — adjusted net loss improved steadily from FY2023 -RMB 154 million → FY2024 -RMB 117 million → FY2025 -RMB 66 million → H1 2026 +RMB 3.19 million, but the H1 turnaround relies on SBC add-backs and government grants while the statutory figure is still deteriorating; ② Accelerated disposal of legacy assets — in June 2026, AInnovation sold a 33.5% stake in Haoya AInnovation (automotive automation) for RMB 20.10 million (2022 acquisition consideration: RMB 153 million; goodwill fully impaired in FY2024), sharpening focus; ③ Policy order window opening — the "AI + Manufacturing" special action by MIIT and seven other ministries (2026-01) sets acceptance milestones of 1,000 industrial AI agents and 500 typical scenarios by 2027; 2026Q4–2027H1 will see dense provincial/municipal list releases, and the company's registered base in Shandong (Qingdao) and product positioning (the first domestic industrial AI agent to receive CAICT's top Trusted AI rating of Level 4+) qualify it for inclusion.
Primary stock-price drivers (ranked by 12-month importance): ① Sustainability of adjusted profitability in H2 2026 — full-year breakeven is the single biggest variable shifting the valuation anchor from P/S to earnings multiples; leading indicator is whether contract liabilities recover from RMB 60.26 million to above RMB 80 million; ② Policy-to-order conversion — provincial/municipal pilot/demonstration lists and ten-million-level flagship orders; ③ Receivables quality and cash burn — quarterly impairment charges and the half-yearly net change in cash and equivalents (H1 net decrease of RMB 113 million).
Expectation gap: Market anchor (reverse-engineered from price, fairly reliable): current price implies an integrator pricing of ~2.8%–3.5% steady-state net margin, EV/S 2026E 0.70x — a ~30% discount to the turnaround precedent 4Paradigm's P/S TTM of 1.65x; sell-side target prices (Futu page average HKD 12.46) are an aggregation of stale 2025 values (Haitong International 14.48 @2025-09, CICC 8.5, Guotai Haitong 5.60 @2025-04), with a 2026 coverage vacuum — stale references only, not current consensus. This report's base case (~50% probability) requires revenue CAGR of 18%–20% and ~5% adjusted net margin by 2028 — the former consistent with the past 18 months' actuals, the latter below the level 4Paradigm has already demonstrated (H1 2026 statutory net margin 3.4%), so neither is an above-consensus assumption; however, the adverse movement in contract liabilities and impairments suggests the discount is not entirely irrational.
Adjusted net profit of RMB 3.19 million is only 0.38% of revenue; excluding government grants, the adjusted figure is about -RMB 6.04 million — the turnaround is jointly propped up by "grants + interest-type income (combined ~RMB 12.57 million)" and "SBC add-back." SBC widened 30.7% YoY (H1 2025: only RMB 3.70 million), and the gap between adjusted and statutory figures is widening, not converging. The high H2 2025 base (revenue RMB 814 million, adjusted loss RMB 59 million) means full-year adjusted breakeven requires an H2 adjusted profit — the margin for error is near zero. Six consecutive quarters of gross-margin improvement (33.6%→35.4%, four verifiable reporting-period data points in the run) and falling expense ratios (selling expense ratio 10.5%→7.6%) are genuine operational improvement; the directional call holds, but the evidence chain for "inflection confirmed" is not yet closed.
Reverse-engineering the current price: EV ÷ 25x ≈ implied steady-state net profit ~RMB 50 million, implying ~2.8% net margin — i.e., the market only requires the company to remain "today's 3%-net-margin integrator," while the company's trajectory is six quarters of gross-margin expansion × 38% industry spending growth. But the bear case must be honestly recorded: ① The net cash is essentially residue from the 2022 IPO (net RMB 871 million) and the 2023 placement (net HKD 379 million); operating cash flow was cumulatively negative ~RMB 260 million over FY2023–2025, and cash and equivalents fell another RMB 113 million in H1 2026 — the cushion is shrinking, not building; ② The discount contains a quantifiable governance component (VAM disclosure violations, three changes of use of proceeds — see E4), not all "unpriced option"; ③ A low percentile is not in itself a buy reason — HK micro-caps can stay at low percentiles for years. Realization of the cushion depends on buybacks and impairment convergence, not automatic mean reversion.
The claims must be presented side by side: the FY2025 annual report's "No.1 in industrial large-model applications" and the 2026 interim report's "No.5 in large-model platform privatization" are two different category bases; the latest reporting period no longer claims the top spot. IDC's studies do not disclose absolute market-share values for this category, so the ranking's substance cannot be independently verified. The jump in "repeat purchase rate from 17.0% to 50.9%" (FY2024→FY2025) also requires a basis explanation. But the following facts are hard: the policy's 2027 acceptance milestone maps directly onto the company's core business (industrial AI agents); Shandong/Shenzhen/Guizhou provincial rules launched intensively in H1 2026; the company's revenue recovery (FY2025 +23.8%, H1 2026 +18.6%) is in sync with industry momentum. Counter-evidence to watch: H1 2026 growth slowed 5.2pp vs. FY2025, and the systems-integrator channel share rose to 60.3% (growth driven by channel volume rather than direct-customer penetration), in tension with the "top-tier productization" narrative; moreover, as of this report's date, no company announcements of provincial/municipal demonstration-list inclusion or ten-million-level new orders have appeared in the run — the policy option remains an option.
Three less-discussed details: ① Financial services segment gross margin slid from 32.9% to 21.1% in six months (revenue +30% but costs +53%) — high-margin business under pressure; ② Of RMB 55 million in bank borrowings, RMB 48 million requires personal guarantees from Qingdao Aolipu minority shareholders — subsidiary credit independence in doubt; ③ Deferred tax assets have been written to zero; at FY2025 year-end RMB 18.80 million of deposits and equity in two subsidiaries were frozen due to litigation (restricted cash fell to RMB 2.95 million in H1 2026, suggesting release but no formal announcement). If H2 impairment ≥RMB 40 million or contract liabilities stay below RMB 80 million, this risk transmits directly into C1's falsification path.
This and C2 are two sides of one coin: the cushion exists, but without external sponsorship capital there are only two paths to re-rating: "company buybacks + hard earnings data." The HKD 100 million mandate at current prices could retire ~4.7% of ex-treasury share capital, yet actual execution is under 10% and has been suspended since July — management not accelerating at depressed prices is the behavioral signal to watch most closely. Conversely, if buybacks resume and accelerate, combined with FY2026 annual-report confirmation of full-year adjusted profitability, the low float would equally amplify upside elasticity (reference the +11% move the day after the 2026-06-12 Yunxi (DataCanvas) partnership announcement).
| Metric (RMB million) | FY2023 | FY2024 | FY2025 | H1 2025 | H1 2026 |
|---|---|---|---|---|---|
| Revenue | 1,751.0 | 1,221.8 | 1,512.6 | 699.0 | 829.0 |
| Revenue YoY | +12.4% | -30.2% | +23.8% | — | +18.6% |
| Gross margin | 33.6% | 34.6% | 35.0% | 35.0% | 35.4% |
| Net profit attributable to shareholders | -582.3 | -593.8 | -250.1 | -56.2 | -65.1 |
| Adjusted net loss/profit (Non-IFRS) | -154.2 | -117.3 | -65.7 | -6.7 | +3.2 |
| Operating cash flow | -180.3 | -35.8 | -43.8 | -8.4 | Not disclosed* |
| Free cash flow | -187.3 | -39.8 | -64.5 | — | — |
| Cash + restricted cash (period end) | 1,365.1 | 1,211.5 | 854.2 | — | 721.1 |
| Interest-bearing debt (period end) | 156.4 | 181.1 | 160.9 | — | 87.2 |
| Net cash (period end) | 1,208.7 | 1,030.4 | 693.3 | — | 633.9 |
| Liabilities/total assets (period end) | — | — | 38.96% | — | 37.37% |
*The H1 2026 interim report did not disclose a cash flow statement; cash and equivalents declined RMB 112.7 million over six months (RMB 831 million → 718 million); the operating/investing/financing split is unavailable. "Adjusted" is the company's Non-IFRS basis (adding back SBC, amortization of acquired intangibles, fair-value changes, etc.).
Reasons for metric changes (items ≥±20% YoY excerpted): FY2024 revenue -30.2% — management cited a deliberate focus on high-quality revenue and business restructuring, plus concentrated impairment of acquisition goodwill and intangibles of RMB 228 million in the period (Haoya AInnovation goodwill fully impaired at RMB 96.38 million, attributed to sharply lower orders from the auto-industry price war); FY2025 revenue +23.8%, net loss narrowed 57.9% — CEO cited achieving the goal of "from defense to offense, returning to growth"; selling expenses -22.9%, administrative expenses -19.9%; H1 2026 net loss widened 15.9% — financial-asset impairment of RMB 35.6 million (+767% YoY, higher receivables provisions) compounded by government grants -55.7%; contract liabilities -61.3% (vs. start of year) and raw materials -87.0% — unexplained by the company; decline in other income — tapering of local government fiscal subsidies.
Revenue RMB 829 million (+18.6%), of which manufacturing RMB 676 million (+21.6%, 81.5% of total), financial services RMB 91 million (+30.0%, 11.0%), other industries -15.1%; gross margin 35.4% (+0.4pp). All three expense ratios declined: selling 10.5%→7.6%, administrative down to 11.1%, R&D 23.5%→20.8% — operating leverage is starting to show. Adjusted net profit of RMB 3.19 million fell within the August 11 positive-profit-alert range (RMB 2 million–4 million) — "delivered but not above expectations"; however, the statutory net loss widened 15.9%, and the gap between the two bases (SBC of RMB 48.32 million) widened YoY. The stock fell -1.6% the day after the results and -3.1% on day three — the market assigned no value to "RMB 3-million-scale" profitability, shifting focus to receivables impairment and contract liabilities. Based on historical seasonality (FY2025 H2 revenue was 53.8% of full year), H2 2026 revenue of ~RMB 890 million–1.00 billion implies a full-year range of RMB 1.72–1.83 billion (+13.7% to +21.0%); full-year adjusted breakeven requires an H2 adjusted loss of no more than ~RMB 3.2 million — the single biggest watch item for H2. No "above/below expectations" market-expectation conclusion is drawn here, given the absence of a comparable active 2026 sell-side consensus.
Business model: Project-based AI solutions plus integrated software-hardware delivery. Materials and subcontracting account for roughly 77% of COGS; revenue is predominantly point-in-time recognized (H1 2026 product and solutions sales at 90.2%; one-off sales overall at 95.5%), while quasi-recurring "data solution services" account for only 4.5%, down 48.6% YoY — recurring revenue is low, and subscription/ARR is not separately disclosed. Light CapEx, heavy on headcount: CapEx/depreciation for FY2023–2025 was 0.07/0.04/0.32 — not an asset-heavy model; the key variables for margins are labor productivity and the share of standardized products, not capacity.
Cash content of earnings: OCF has been negative for three consecutive years (-180/-36/-44 million yuan), and in FY2025, the same year losses narrowed 58%, OCF actually deteriorated versus FY2024 — book loss reduction has not yet translated into cash. FCF over the same period was -187/-40/-64 million yuan. In H1 2026, cash and equivalents declined by a net 113 million yuan (including a HK$9.64 million buyback and operating cash burn; the split cannot be broken out). Annualizing FY2025 FCF of -64 million yuan, the 721 million yuan cash pile could support roughly 11 years; but annualizing the H1 net decline rate (-225 million yuan, including one-offs such as M&A/buybacks) supports only about 3 years — the true burn rate lies between the two. The absence of a cash flow statement in the interim report is itself a disclosure-quality flaw.
Recurring profitability test: The adjusted figures add back in full the SBC that recurs every year (FY2023–2025 SBC of 290/150/90 million yuan respectively, plus another 48 million yuan in H1 2026). In H1 2026, total add-backs of 66.03 million yuan exceeded the period loss of 62.84 million yuan — the "first turnaround to profit" is a marginal result of add-backs slightly exceeding the loss; after further excluding government grants of 9.22 million yuan, the adjusted figure was approximately -6.04 million yuan. On a statutory basis, the company is not yet profitable; on an adjusted basis excluding grants, the core business still falls just short. On the flip side, the six consecutive years of gross margin improvement (29.1% in 2021 → 35.4%; the company calls it "the 6th consecutive year of improvement") and declining expense ratios are real, and the loss engines (SBC + impairments) are either non-cash or controllable items.
Return on capital: ROIC is negative during the loss-making period; existing disclosures do not support a meaningful ROIC calculation — this is "not yet proven" rather than "disproven." The reference point is the viable path demonstrated by 4Paradigm (statutory net margin of 3.4% in H1 2026 after its platform transformation).
Quality red flags: ① OCF has diverged from book loss reduction for three years; ② no dividends since listing (accumulated losses mean no distributable reserves), yet in 2023 the company conducted a placement at a 16.17% discount diluting shareholders, and use of proceeds was redirected three times — the capital-operations track record is both unfriendly and friendly to minority shareholders (sustained buybacks over the past two years are a positive); ③ customer concentration is not high (largest customer at 5.1% of revenue), but the rapid rise of the system integrator channel from 32.1% → 46.9% → 60.3% is a hidden single-channel dependency.
Credibility track record: partially delivered, with an optimistic bias in framing. ① The FY2024 annual report promised a "shift from defense to offense, return to growth" → FY2025 revenue +23.8% and adjusted losses narrowed 43.9% — delivered; ② the positive profit alert of 2026-08-13 flagged adjusted net profit of 2–4 million yuan → the actual figure of 3.19 million yuan landed in the range — delivered; ③ "steadily advancing toward full profitability" → H1 2026 turned marginally positive only on a Non-IFRS basis while the statutory loss widened — partially delivered. Notable framing issue: the profit alert disclosed only the adjusted range and made no mention of the widened statutory loss — selective disclosure.
Shareholder friendliness: neutral. No dividends (no distributable reserves); buybacks are real but restrained — 8.448 million shares for HK$48.2 million in 2025, plus another 2.068 million shares for HK$9.64 million in H1 2026; execution of the new HK$100 million mandate is only 9.6%, and it has been suspended since July 2026. The June 2023 placement of 19.9 million shares at HK$19.70 (net proceeds of HK$379 million, a 16.17% discount) is a dilution record.
Risk signals: ① The delayed disclosure of a change in the Auli Performance metrics constitutes a breach of the Listing Rules (overpayment of 38.29 million yuan, attributed to departed staff); the promised internal-control remediation is due before September 2026 — that is this very month and needs verification; ② in December 2024, 15.26 million awarded incentive shares were cancelled with accelerated recognition of 83 million yuan in SBC, and in April 2025 approximately 47.7 million shares were re-granted for zero consideration — traces of cross-period manipulation in incentive accounting; ③ use of proceeds was changed three times plus three extensions to 2029, with the 104 million yuan "strategic expansion" item shifted entirely to working capital — the originally planned commercialization investment has effectively been abandoned.
| Segment (H1 2026) | Revenue share | Gross margin | YoY | Business logic in one line |
|---|---|---|---|---|
| Manufacturing (AI products & solutions) | 81.5% | 38.8% (estimated) | +21.6% | Industrial large models + agents + integrated software-hardware; focus on core business rising for 6 consecutive years |
| Financial services (data governance/platform) | 11.0% | 21.1% (estimated) | +30.0% | Revenue up, profit not: rising share of low-margin hardware solutions; semi-annual gross margin -11.8pp |
| Other industries | 7.5% | Not broken out | -15.1% | Deliberate contraction |
| By type: product & solutions sales | 95.5% | — | +26.4% | Point-in-time recognized integrated sales are the overwhelming majority |
| By type: data solution services | 4.5% | — | -48.6% | Quasi-recurring revenue shrinking; productization not yet reflected in revenue mix |
Gross profit driver: Manufacturing. Estimated from revenue × gross margin, manufacturing contributes about 262 million yuan of gross profit, or 89.3% of group gross profit (about 293 million yuan) — despite financial services' higher revenue growth, its 21.1% gross margin yields only about 19 million yuan of gross profit contribution. The 17.7pp gap between manufacturing's gross margin (38.8%) and financial services' (21.1%) stems from the former's accumulated industrial know-how in software and scenario-based repeat purchases versus the latter's price competition in hardware integration (the recurring goodwill impairments on Shanghai Luopan stem from this segment). Growth quality caveat: the fastest-growing segment, financial services, is precisely the one with collapsing gross margins; revenue-mix improvement (rising manufacturing share) coexists with deteriorating quality within segments.
Accounting red flags: ① Post-hoc adjustment of the earn-out performance metrics with delayed disclosure (high severity) — under the original terms the 2023/2024 completion rates of 0% would have required no payment; after adjustment (0.01%), the company instead overpaid 38.29 million yuan and avoided clawback; ② Non-GAAP adds back recurring SBC in full (medium) — the "turnaround" narrative rests on payroll costs that recur every year; ③ one-off large impairments concentrated at the earnings trough (medium) — in FY2024, with revenue -30.2%, 228 million yuan of impairments were booked, and the next year showed a 57.9% loss reduction, flattering the base for the following period; ④ sharply swinging receivables impairment provisioning (medium) — 87 million (FY2023) → 0.9 million (FY2024) → 20 million (FY2025) → 36 million (H1 2026); management's framing shifted from "strengthening receivables management" to "increased provisions," inconsistent before and after; ⑤ frequent changes to use of proceeds (low); ⑥ serial downward revisions to goodwill impairment test assumptions (low) — Shanghai Luopan's revenue growth forecast was cut from 2.0%–17.5% to -24.5%–14.2%; the impairment buffer on remaining goodwill of 135 million yuan (including 88.53 million yuan for Auli Performance) is only about 26.19 million yuan.
Cross-period anomalies: ① OCF has diverged from statutory net loss attributable to shareholders for three consecutive years without company explanation; ② contract liabilities plunged from 156 million to 60 million yuan (-61.3%) without explanation — a weakening leading indicator of pre-collected orders; ③ the system integrator channel's revenue share rose 32.1% → 46.9% → 60.3% without explanation — deepening channel dependency typically brings pressure on gross margins and collections quality; ④ R&D expense ratio declining 25.7% → 29.1% → 26.2% → 20.8% while SBC shrank from 290 million yuan to 48 million yuan (half-year) — R&D intensity and incentive expense contracting in tandem; whether this is "efficiency gains" or "investment gaps" needs verification in the FY2026 annual report; ⑤ raw materials -87% / prepayments to suppliers -54.8% / inventory -34.5%, contracting in tandem with contract liabilities — a systemic signal pointing to a shrinking order backlog.
Current market data (close of 2026-09-01): Share price HK$3.965; market cap HK$2.193 billion (ex-treasury share count 553.03 million shares); net cash approximately HK$735 million (33.5% of market cap); EV approximately 1.25 billion yuan. EV/Sales 0.83x on 2025A and approximately 0.70x on 2026E; P/S TTM 1.14x; P/B approximately 1.49x (28th percentile over 1 year / 51st percentile over 3 years — percentile for reference only: with the company at the loss-to-profit threshold, P/B percentiles have limited signal value); PE (TTM) is negative and not applicable. Market cap sits at roughly the 8th percentile since listing (median approximately HK$3.8 billion) — cited as background fact, not a buying rationale. FX: 1 CNY = 1.1664 HKD (as of 2026-09-02).
Peer benchmarking (data as of 2026-09-01/02):
| Company | Market cap | P/S TTM | Revenue growth | Profitability | Key difference vs. this company |
|---|---|---|---|---|---|
| AInnovation 02121.HK | HK$2.193bn | 1.14x | +18.6% (H1 26) | Marginally positive on adjusted basis | Deep AI+manufacturing focus; smallest scale, no southbound flows |
| 4Paradigm 06682.HK | ~HK$15.9bn | 1.65x | +35.6% (2025) | H1 2026 statutory net margin 3.4% | Cross-industry platform, 4.7x the scale; proven turnaround precedent |
| CloudWalk 688327.SH | ~11.1bn yuan | 25.7x | -40.7% (H1 26) | Deep losses, shrinking balance sheet | A-share liquidity/theme premium, not a fundamental anchor |
| TJ Innova 688003.SH | ~15.2bn yuan | 7.3x | +25.0% (TTM) | Profitable (thin ex-one-offs) | Selling equipment vs. selling cognition; 39% gross margin |
| Deep Glint 688207.SH | ~4.6bn yuan | 28.4x | +18.7% (H1 26) | Deep losses | CV niche; A-share premium sample |
The three A-share names (CloudWalk/TJ Innova/Deep Glint) trade at 25.7x/7.3x/28.4x P/S, containing large liquidity/theme premiums and unusable as fundamental anchors; this company's true valuation coordinate is 4Paradigm — also Hong Kong-listed, also in platform transformation, and already one step ahead in turning profitable; its 1.65x P/S TTM implies a 30% discount for this company.
Market-implied expectations: EV ÷ 25x ≈ implied steady-state net profit of about 50 million yuan (net margin roughly 2.8% — exactly where 4Paradigm stands today). In one sentence: the current price requires the company to remain "today's 3%-net-margin integrator," while the company's trajectory (six years of gross margin gains × policy order window × industry spending growing 38%) points higher. Against the industry demand math: incremental industry spend of 2024–2028 is about 56 billion yuan (90 billion minus an approximately 34 billion base); the company needs only a roughly 1.5%–2% average annual capture rate of that increment (implying its own 18%–20% CAGR) to support the base case — a modest requirement, but one needing order conversion for validation. The reverse test also holds: if policy order conversion is zero, the implied 3% net margin is fair pricing, not mispricing.
Three layers of value: Asset value (book equity per share) of about HK$2.66 = liquidation floor; EPV (zero-growth earnings + net cash) of about HK$1.61 (normalized operating earnings taken as the midpoint of a 0–35 million yuan range, ~18 million yuan; WACC 13% — small-cap HK liquidity discount plus execution risk; on a full-cost SBC basis normalized earnings ≈ 0, and EPV degenerates to net cash of about HK$1.33 per share); the growth option is worth about HK$2.36, or 59.3% of the current price — the current price is mainly supported by the growth option, not by assets or current earnings power; this underpins the stock's high-volatility character: option value swings both ways with order/policy events.
Three scenarios and odds (this report's estimates; exit multiples anchored independently of the company's current price):
| Scenario | Probability | Fair value range (HKD) | vs. current price | Key swing factors |
|---|---|---|---|---|
| Bear | 30% | 1.5–2.0 (midpoint 1.75) | -50%~-62% | Inflection disproven: H2 adjusted returns to loss, full-year impairments ≥75 million, cash burn continues → market cap converges toward net cash + residual value (~730–930 million yuan) |
| Base | 50% | 5.0–6.2 (midpoint 5.6) | +26%~+56% | Revenue CAGR 18%–20% (reaching 2.49–2.61 billion yuan by FY2028), ~5% adjusted net margin in 2028 (124–131 million yuan), exit PE 25–30x (≈PS 1.25–1.5x, a 9%–24% discount to 4Paradigm's current 1.65x), discounted at WACC 13% over 2.33 years |
| Bull | 20% | 9.2–10.3 (midpoint 9.75) | +132%~+160% | Full delivery of policy orders: CAGR 30% (3.32 billion yuan), 7% net margin (233 million yuan), exit PE 25–28x (≈PS 1.75–1.96x — a premium version of 4Paradigm, which is 2.5x the size with proven profitability) |
Bear-case anchoring note: no new named bearish 2026 forecasts exist in the market (the lowest sell-side target is Haitong International's HK$5.60 @ 2025-04, a stale "Overweight" rating that does not reflect new facts such as the surge in impairments and widened statutory loss in the 2026 interim report), so the bear case is constructed from first-principles falsification: net cash of 630 million yuan plus business residual value of 100–300 million yuan, corresponding to about HK$1.5–2.0, consistent with the historical small-cap washout experience of "1.5x net cash ≈ HK$1.86." Probability-weighted fair value is about HK$5.28 (roughly +33% versus the current price); odds are asymmetrically positive, but delivery hinges on two dates — the 2027-03 annual report and policy orders — and low liquidity amplifies two-way volatility. The base-case exit multiples (PE 25–30x / PS 1.25–1.5x) are anchored to 4Paradigm's current trading level with a liquidity discount applied — the company's own 5-year historical midpoint (market cap median ~HK$3.8 billion, ~2.3x P/S on current revenue) is shown for comparison only: base-case assumptions are already significantly below the historical midpoint, with no attempt to inflate the valuation using historical peaks.
In-house earnings forecast (reconciliation anchor):
| Period | Revenue (100M yuan) | Adjusted net profit (100M yuan) | Statutory net profit attributable (100M yuan) | Key assumptions |
|---|---|---|---|---|
| FY2026E | 17.2–18.3 (+13.7%~+21.0%) | 0.05–0.35 | -1.2 ~ -0.6 | H2 revenue 890 million–1.00 billion (+9.5%~+23%); full-year SBC ~100 million; impairments 40–75 million |
| FY2027E | 20.5–22.5 (+16%~+28%) | 0.5–1.1 | -0.4 ~ +0.3 | Batch replication of agents + gross margin 36%–37%; SBC easing to ~80 million |
Methodology: H1 actuals plus H2 seasonal extrapolation; "adjusted" is Non-IFRS (includes government grants; lower excluding grants); no management quantitative guidance and no comparable 2026 sell-side consensus available.
Conclusion: Undervalued — quality (improving, not fully proven) and price (EV/S 0.70x, net cash at one-third of market cap) stated separately. Target price HK$5.0–6.2 = base-case fair value; margin of safety approximately 26%. The conditionality of the judgment must be made explicit: revenue growth falling below 15%, adjusted margin ramp-up failing, or non-converging SBC delaying statutory profitability — if any one of the three fails, the thesis slides into the bear case.
Market size. AInnovation's track is "AI + Manufacturing" — industry-specific solutions built on computer vision and industrial large models as the technology foundation, deployed as industrial software (MOM/MES), quality inspection systems, and industrial robots. Size estimates (all in RMB): ① IDC, "Forecast of AI Spending by Chinese Industrial Enterprises": approaching RMB 90 billion by 2028, 2024–2028 CAGR of 38% — the headline figure of this report, from a first-tier industry association-level source; ② IDC, "China AI Software Market Share, 2024": computer vision applications market at RMB 12.34 billion (+21.2%), machine learning platforms at RMB 3.45 billion (+22.7%) — the two sub-markets the company directly participates in; ③ IDC: the "AI + industrial software" sub-market growing at a 2024–2030 CAGR of 49% (RMB 5.30 billion → RMB 38.94 billion); global active AI agents at a 2025–2030 CAGR of 139%, exceeding 2.216 billion by 2030; ④ EO Intelligence (cross-reference, low reliability, unverified): China's AI + manufacturing at roughly RMB 14.1 billion in 2025, growth of 40%+. The growth structure is clear: at the bottom is the aggregate expansion of AI spending by industrial enterprises (38%), on top of which software/agent-based forms are penetrating faster (49%–139%) — the industry is switching from "single-point visual quality inspection projects" to full-process, systematized applications of "platform + multi-agent + robotics"; this is the industrial foundation for the valuation paradigm shifting from system integrator to platform provider.
Quantified chain of the structural demand inflection: Driver variables = policy (eight-ministry special action with 2027 acceptance targets: 1,000 industrial AI agents / 500 scenarios / 100 datasets; State Council "AI+" action opinion, August 2025) × rigid demand for intelligent manufacturing upgrades (shifting from exploratory moves by top players to economy-wide quality improvement, cost reduction, and efficiency gains); change in unit usage = large models/agents expand AI budgets from a single quality-inspection workstation to multiple stages across design, process, production, O&M, and energy (single-customer value jumping from hundreds-of-thousands-RMB projects to "platform + multi-agent + robotics" bundles; precise multiples lack third-party estimates); penetration pace = the single-digit share of industrial AI spending within manufacturing IT budgets keeps rising, with 2025–2027 the steepest ramp segment (ahead of policy acceptance milestones); company share = No. 1 in industrial large-model applications (IDC, FY2025 annual report) / No. 5 in private deployment of large-model platforms + No. 3 in visual AI (latest interim 2026 basis), 633 customers (+21.5%), revenue-based repurchase rate of 50.9%, key-account revenue share of 72.8% — the company sits in the first tier in capturing incremental demand with an upward trend; absolute share percentages are not disclosed (IDC research of this type is often vendor-commissioned with no public share figures).
Value chain and value distribution: Upstream = AI chips/compute (NVIDIA, Ascend, intelligent computing centers; export controls increase procurement uncertainty) + general-purpose foundation models (mainly open source; DeepSeek and others rapidly easing cost constraints) — upstream compute is highly concentrated with strong bargaining power, but open-sourcing of foundation models is lowering application-layer barriers and costs; midstream = industry models and platform layer (MaaS/PaaS, China machine learning platform market at RMB 3.45 billion in 2024), players being 4Paradigm, Huawei Cloud, AInnovation, DataCanvas, Transwarp — AInnovation's AInnoGC industrial large model + enterprise agent platform (AgentBuilder/DeepAgent) sits at this layer; downstream = scenario solutions and integration delivery, serving large manufacturing customers in steel, automotive, equipment, and energy (centralized procurement, project tendering, relatively weak supplier bargaining power). Gross margin distribution: pure software vendors 60%+, pure integrators about 20%, AInnovation at 35.4% in the middle and rising year by year — value is concentrating in the "industry model + scenario software" layer; the company's gross margin structure is direct evidence of its improving position in the value chain, though its bargaining power vis-à-vis large downstream customers remains weak, partially offset by scenario depth and repurchases.
Supply-demand and competitive landscape: Demand-side growth (38%) outpaces effective supply capacity (teams that understand industrial semantics and can deliver closed-loop solutions are scarce), producing a tight balance of "structural effective supply shortage + nominal supply surplus" — many can do PoCs, few can deliver at scale and win customer repurchases. Supply tiering: ① general big tech (Huawei Cloud/Baidu/Tencent/Alibaba) moving down-market with compute and foundation models; ② independent AI vendors (4Paradigm, AInnovation, SenseTime, CloudWalk); ③ vision equipment makers (Hikvision, Dahua, Tianzhun) entering via hardware; ④ regional small and mid-sized integrators. Concentration: highly dispersed with tiered concentration — machine learning platform layer CR5 ≈ 4Paradigm/Huawei Cloud/AInnovation/DataCanvas/Transwarp; computer vision applications layer CR5 = SenseTime/Hikvision/AInnovation/Dahua/China Telecom AI (IDC 2024); no authoritative CR3 figure for the overall solutions market. Entry barriers: industrial semantics/process know-how and accumulated industry data (hardest to replicate), the 1–2 year validation cycle and trust barrier of large manufacturing customers, platform-level R&D capex, end-to-end delivery systems; conversely, pure algorithmic capability no longer constitutes a barrier given the diffusion of open-source foundations. Competition is intense and intensifying: big tech moving down-market with low-priced compute + subsidies; IDC (Aug 2025) says the large-model platform layer has entered a "knockout stage" that will transmit to the application layer — undifferentiated project-based vendors will be shaken out; this is both a risk (95.5% of the company's revenue is still project-based) and an opportunity (head concentration after the shakeout). Substitution threats: manufacturers building in-house teams + open-source models (small and mid-sized scenarios), capability spillover from general-purpose large models, and cost-based substitution by traditional automation equipment in some scenarios.
Cycle and regulation: The industry is in the early-to-mid growth stage of its life cycle; 2025–2027 is the first year of commercial-scale agent deployment, accompanied by intra-industry reshuffling — "aggregate growth up + landscape diverging" coexist. Leading indicators: ① provincial/municipal special tender volumes and pilot lists (progress of the 1,000-agent/500-scenario rollout); ② IDC tracking of AI spending growth by industrial enterprises; ③ vendor-side customer growth, revenue-based repurchase rate, and software/subscription revenue share. Regulatory direction: State Council "AI+" action, eight-ministry "AI + Manufacturing" special action, reinforced new industrialization and "15th Five-Year Plan" smart manufacturing, and embodied AI real-scenario training programs — the policy mainline overlaps heavily with AInnovation's focus (positive); constraints: generative AI service management measures, Data Security Law and industrial-control data compliance, and U.S. export controls on compute to China (neutral-to-negative tail).
Company's industry positioning: leading niche player (not an all-around leader). Share trend is upward (revenue growth of 18.6%–23.8% above the low-single-digit nominal industry growth; customers +21.5%); three pillars of the moat: ① industrial-semantics know-how and the "industrial ontology" (translating equipment/process/supply-chain data into machine-understandable business language — the hardest asset to replicate once open source has commoditized algorithms); ② validation barriers with large manufacturing customers and high repurchase (post-entry repurchase exceeds half in steel/automotive/PV scenarios); ③ the "one model, one body, two wings" software-hardware positioning (AInnoGC + agent platform + MOM industrial software rebuild + ChatRobot embodied robots) sitting squarely on the policy mainline. Relative weaknesses: small absolute scale (about 1/5 of 4Paradigm), 93% of revenue still one-off project sales, subscription/ARR not disclosed — the "productization rate" of its leap from project-based solution provider to platform company is the ultimate determinant of its industry standing. Note on differing market-position claims: the company's FY2025 annual report cited "No. 1 share in China's industrial large-model applications" (IDC), while the 2026 interim report shifted to "No. 5 in private deployment of large-model platforms (the only top-five player focused on manufacturing) + No. 3 in visual AI" (IDC) — the two bases define categories differently (the former is a recently created category whose quality cannot be independently verified); this report uses the latest interim basis, with the annual-report basis listed for reference.
The generic financial framework for the AI solutions industry misses three defining metrics, listed separately:
① Backlog and contract liabilities (leading indicator of revenue): The company does not disclose total backlog; unfulfilled performance obligations were RMB 649 million at FY2024 year-end (vs. RMB 598 million at FY2023 year-end, +6.7%), with disclosure of this item discontinued from FY2025. Contract liabilities (advance receipts) recovered to RMB 156 million at FY2025 year-end, then plunged to RMB 60 million in H1 2026 (-61.3%) — this is currently the most important negative leading signal: advances are the ammunition between order landing and revenue recognition; their plunge, combined with simultaneous contraction of raw materials/inventory, points to dual pressure on H2 revenue recognition and cash flow, and the company's lack of explanation is a disclosure flaw.
② Recurring revenue share (business model quality): Quasi-recurring data solution services were 7.9% in FY2025, falling to 4.5% in H1 2026 (-48.6%); subscription revenue is not disclosed. Against the industry trend judgment of "shifting from project-based to platform/product-based" (IDC: buyers demand clear ROI and faster deployment; vendors compete on repurchase rates and software/subscription share), the productization evidence in the company's revenue structure is currently weaker than the signal given by its six consecutive quarters of gross margin improvement — the margin improvement stems more from project mix optimization and scale effects than from subscription revenue volume.
③ Repurchase and customer quality: Total customers rose 521→633 (+21.5%), but "key customers" only 68→69 (+1), with their revenue rising from RMB 845 million to RMB 1.101 billion (+32% per customer); the sudden jump in revenue-based repurchase rate from 17.0% to 50.9% lacks a basis-of-preparation explanation (possibly a change in statistical base or definition) — authenticity is questionable, but the direction (deepening repurchase) is consistent with the margin structure. Also watch channel structure: the system-integrator channel share rose 32.1%→46.9%→60.3% — channelization by a project-based vendor is typically the alternative path of "failed productization" (using channels for volume to sustain growth at the cost of margin and customer stickiness), which is in tension with the "first tier in industrial large models" narrative; if this continues rising in the FY2026 annual report, the productization judgment should be downgraded.
Overall assessment: cautiously bullish, confidence 0.55, time horizon 12–18 months. The price-fundamental mismatch is clear (EV/S 0.70x + net cash at 1/3 of market cap vs. industry growth of 38% + policy acceptance milestones), but realization depends on two timed events (FY2026 annual report in March 2027, policy orders in 2026Q4–2027H1), and low liquidity means "undervaluation" can persist for a long time. Strategy: target range at base-case fair value of HK$5.0–6.2; the current price of HK$3.965 offers roughly 26% margin of safety, suitable for capital that can tolerate 50%-level drawdowns (bear case HK$1.5–2.0) and has a relaxed accumulation window, participating in small steps; resumption of buybacks and replenishment of contract liabilities are the two confirmation signals before adding positions; do not add until the buyback suspension since July is lifted.
Risk and catalyst calendar:
Falsification conditions (any single trigger requires reassessment): ① FY2026 annual report shows adjusted net profit turning negative (an H2 loss of about RMB 3.2 million would turn the full year negative); ② full-year impairment of financial assets ≥ RMB 75 million; ③ contract liabilities still below RMB 80 million at end-2026; ④ share price breaking below HK$3.0 (market begins pricing at a discount to net cash); ⑤ placement/rights-issue dilution during the low-valuation window; ⑥ further regulatory action over the late-disclosure violation. Upside catalysts: ① provincial/municipal industrial AI agent demonstration lists / announcements of RMB-10-million-level orders (2026Q4–2027H1); ② Q3/Q4 voluntary business update announcements (precedent in Nov 2025; a 6/12 partnership announcement gained +11% the next day, showing market elasticity); ③ FY2026 annual report confirming full-year adjusted profit of ≥ RMB 20 million; ④ buyback resumption and acceleration (about 90% of the HK$100 million authorization remaining); ⑤ sell-side re-coverage (no coverage in 2026; historical TP range of HK$5.6–14.48 all stale).
Report date: 2026-09-02. Price basis: 2026-09-01 close of HK$3.965 (closing price of a completed trading day). Financial data sources: AInnovation FY2023–FY2025 annual reports, 2026 interim results announcement, and HKEX disclosures; industry data sources: IDC and the eight-ministry document including MIIT; peer data as of 2026-09-01/02. This report is independent research and analysis and does not constitute investment advice.